Table 1.
Clinical features of ICC patients with positive AFP
AFP |
|||
+ (n = 32) | - (n = 99) | P value | |
Gender (M/F) | 24/8 | 66/33 | NS |
Age (yr) | 48.7 ± 11.7 | 54.5 ± 9.9 | 0.007 |
HBsAg + (%) | 25 (78.1) | 38 (38.3) | 0.000 |
Anti-HCV + (%) | 0 | 1 (0.01) | NS |
CA19-9 (> 37 U/mL) (%) | 10 (31.4) | 58 (58.6) | 0.007 |
TBIL (> 17.1 μmol/L) (%) | 17 (53.1) | 39 (39.4) | NS |
ALT (> 40 IU/L) (%) | 16 (50.0) | 26 (26.3) | 0.012 |
AST (> 40 IU/L) (%) | 14 (43.8) | 23 (23.2) | 0.025 |
NS: Not significant; M: Male; F: Female; HBsAg: Hepatitis B surface antigen; HCV: Hepatitis C virus antibody; TBIL: Total bilirubin; AST: Aspartate transaminase; ALT: Alanine transaminase.